Potential of Liposomes for Enhancement of Oral Drug Absorption

Abstract

Oral administration of medication is the first option when patient compliance is considered. However, many barriers face oral absorption of drugs that limit bioavailability in about 90% of therapeutic agents. Utilization of nanoparticulate drug delivery systems is a major strategy for increasing oral absorption. They can improve oral bioavailability through mechanisms such as protection of the drug in the GI tract, increasing cellular contact and residence time of the drug, protection of the drug from presystemic metabolism and efflux and increasing diffusion across the mucosal and epithelial layers. Liposomes are biocompatible carriers employed to improve oral bioavailability of drugs and in addition to the general advantages of nanocarriers for oral delivery, they offer benefits derived from their lipidic bilayer structure. They can better adhere to biomembranes, form mixed-micelle structures with bile salts to increase the solubility of poorly-soluble drugs and are suitable candidates for lymphatic uptake. They have been successful in improving oral bioavailability of a variety of compounds including peptide and proteins, hydrophilic and lipophilic drugs. Stability under GI conditions is the main concern for oral liposomes, however, promising approaches have been suggested to increase the stability of oral liposomes. These include: using appropriate lipid compositions, polymer coating, addition of stabilizing lipids to liposomal structures, preparation of double liposomes and proliposomes and some other innovative methods. The present review focuses on the role of liposomes in improving oral absorption of drugs, the problems encountered, and the types of liposomes designed to overcome these issues. Barriers to oral delivery will be discussed and examples of bioavailability enhancement upon encapsulation in various types of liposomes investigated.

The antimicrobial activity of nanoparticles: present situation and prospects for the future

“…Several types of NPs are currently used for drug delivery: liposomal NPs, 45 solid lipid (SL) NPs, 46,47 polymer-based NPs, polymer micelles, inorganic nanodrug carriers (including magnetic NPs, mesoporous silica NPs, carbon nanomaterials, and quantum dots), terpenoid-based NPs, 48 and dendrimer NPs. 49 As a carrier for the delivery of antibiotics, the main advantages of NPs compared with conventional delivery systems are as follows:…”

In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine

“…15 Encapsulation or entrapment of drugs in liposomes results in distinct changes in the pharmacokinetic and pharmacodynamic properties of free drugs, and in some cases, causes an apparent decrease in toxicity and/or an increase in therapeutic efficacy. 16 In recent years, the use of ligand-receptor-based system for targeted drug delivery has become a hot research topic.…”

Recent Advances in Encapsulation, Protection, and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems

“…Liposomes are comprised of one or more phospholipid bilayers held together by hydrophobic interactions between the non-polar tails (Figure 1) [110][111][112]. They are able to trap hydrophilic BPPs within the water core or between the polar head groups in the phospholipid bilayers [113]. BPPs with hydrophobic regions, including those naturally located in cell walls, can also be trapped in the phospholipid bilayers.…”